It has been reported that tumor infiltration of CD163‐positive macrophages is associated with shortened PFS after the treatment initiation of immune checkpoint inhibitors in patients with NSCLC [6], and shortened OS of patients who were diagnosed as having SCLC between 2017 and 2020 [25]. The gene discussed is CD163; the disease is neoplasm.